Healthcare over the next decade will be shaped by a collision of forces: an aging global population, a growing shortage of doctors, rising costs, and technology that is already pulling medical care out of hospitals and into homes and phones. Some of these shifts are well underway. Others are just reaching the point where they’ll start affecting how you experience a doctor’s visit, a diagnosis, or a hospital stay.
Care Is Moving Out of the Hospital
One of the most concrete changes already in motion is the shift toward treating patients at home rather than in a hospital bed. Hospital-at-home programs send medical teams, equipment, and monitoring technology to a patient’s residence for conditions that traditionally required admission: pneumonia, heart failure flare-ups, serious infections, and chronic lung disease.
The results so far are striking. In a randomized trial of elderly patients admitted through the emergency department, 30-day readmission rates were 7% for those treated at home compared to 23% for those treated in the hospital. A larger case-control study at Mount Sinai Health System found readmission rates of 8.6% for home patients versus 15.6% for inpatients. Costs drop significantly too. One multi-city study of 455 seniors found that per-patient costs were $5,081 for home care versus $7,480 for hospital care, a 32% reduction per patient day. A separate trial put the daily cost savings even higher, at 38%.
These programs expanded rapidly during the pandemic under emergency federal waivers, and hospitals are now lobbying to make them permanent. Over the next decade, expect home-based acute care to become a standard option for a growing list of conditions, particularly for older adults who are more vulnerable to hospital-acquired infections and the disorientation that often comes with inpatient stays.
Wearables Will Do More Than Count Steps
Consumer health devices are crossing into territory that used to require a clinic visit. The FDA has already cleared the first over-the-counter continuous glucose monitor, the Stelo Glucose Biosensor System, which lets people who aren’t on insulin wear a small sensor for up to 15 days and check their glucose levels and trends every 15 minutes on a smartphone app. Previously, continuous glucose monitors were only available by prescription for people with diabetes.
This is a preview of a broader trend. Wearable sensors for heart rhythm, blood oxygen, and sleep quality are already common. The next wave includes non-invasive blood pressure monitoring, earlier detection of irregular heart rhythms, and algorithms that flag warning signs of conditions like atrial fibrillation or sleep apnea before you’d notice symptoms yourself. The practical effect is that by the mid-2030s, many chronic conditions will be caught earlier and managed continuously rather than checked a few times a year at an office visit.
A Doctor Shortage Will Reshape Who You See
The United States is heading into a significant physician shortage. The Association of American Medical Colleges projects that by 2036, the country will be short between 20,200 and 40,400 primary care physicians. Surgical specialties face a gap of 10,100 to 19,900 physicians. Some other specialty areas could see shortages of up to 19,500 doctors, though a few fields like emergency medicine may actually have a surplus.
This shortage will force changes in how care is delivered. Nurse practitioners and physician assistants will take on a larger share of routine primary care. AI-assisted triage and diagnostic tools will help clinicians see more patients by handling preliminary assessments, flagging abnormal lab results, and drafting visit notes. Virtual visits, which surged during the pandemic and then partially receded, will become the default for follow-ups, medication management, and many mental health appointments simply because there won’t be enough doctors to see everyone in person.
For patients, this means your first point of contact for a health concern will increasingly be a non-physician clinician, an AI chatbot doing initial screening, or a video call rather than a face-to-face appointment with a doctor. The quality of care doesn’t have to suffer, but the experience will feel different.
Treatment Tailored to Your Genetics
Pharmacogenomics, the practice of using your genetic profile to predict how you’ll respond to specific medications, is moving from research curiosity to clinical reality. The FDA now lists 676 drugs with pharmacogenomic information on their labels, meaning the drug’s prescribing guidance includes genetic factors that affect dosing, effectiveness, or the risk of side effects.
Right now, genetic testing before prescribing is common mainly in oncology and for a handful of other drugs where the wrong dose can be dangerous. Over the next decade, it will expand into routine care. Before starting an antidepressant, a blood thinner, or a pain medication, your doctor may order a simple genetic test to determine which drug and dose are most likely to work for you. This reduces the trial-and-error period that many patients endure, sometimes for months, when starting new medications. As testing costs continue to fall and more drugs carry genomic labeling, a genetic profile taken once in your twenties could inform prescribing decisions for the rest of your life.
An Aging Population Will Drive Everything
The demographic math behind all these changes is simple and unavoidable. By 2030, one in six people worldwide will be 60 or older. By 2050, the global population over 60 will double to 2.1 billion. The proportion of people over 60 is expected to nearly double from 12% to 22% between 2015 and 2050, and the next decade sits right in the steepest part of that curve.
Older adults are more likely to live with multiple conditions at once: hearing loss, diabetes, chronic lung disease, osteoarthritis, depression, and dementia. And evidence suggests that while people are living longer, the proportion of life spent in good health has stayed roughly constant. That means the extra years are largely years of managing illness. Healthcare systems built around treating one acute problem at a time will need to reorganize around coordinating care for people juggling four or five chronic conditions simultaneously. This is one reason home-based care, remote monitoring, and AI-assisted management are gaining traction so quickly. The volume of patients who need ongoing attention is about to surge, and the traditional model of office visits and hospital stays can’t scale to meet it.
Healthcare Spending Will Keep Climbing
All of this costs money, and the trajectory is steep. The Centers for Medicare and Medicaid Services projects that U.S. national health expenditure will grow at an average of 5.6% per year through 2032, outpacing GDP growth of 4.3% over the same period. Health spending as a share of GDP is expected to rise from 17.3% in 2022 to 19.7% by 2032. That means roughly one in five dollars generated by the American economy will go toward healthcare.
This pressure will intensify the push toward models that reduce costs: home-based care, preventive interventions guided by wearable data, genetic testing that avoids ineffective prescriptions, and AI tools that reduce administrative overhead. It will also force harder conversations about what insurance covers, how much patients pay out of pocket, and whether the current system of employer-sponsored coverage can hold together as costs grow faster than wages. For individuals, the practical reality is that healthcare will consume a larger share of household budgets unless systemic changes in delivery and pricing take hold.
What the Day-to-Day Experience Will Look Like
Zooming out, the patient experience in 2035 will differ from today in tangible ways. A routine checkup might start with data your wearable has already uploaded to your medical record: resting heart rate trends, sleep patterns, glucose readings. Your clinician, possibly a nurse practitioner supported by AI analysis, reviews the data before you arrive, spending the visit on problems the algorithms flagged rather than running through a generic checklist.
If you need a new medication, a pharmacogenomic profile on file helps narrow the options. If you develop a condition that currently requires hospitalization, like a flare-up of heart failure or a treatable infection, there’s a good chance you’ll be offered the option to receive that care at home with remote monitoring and daily check-ins from a medical team. And if you live in a rural area or simply can’t get an appointment because of the physician shortage, virtual care will fill more of the gap than it does today.
None of these changes will arrive uniformly. Wealthier health systems and urban areas will adopt them faster. Rural communities and underfunded hospitals will lag. But the direction is clear, and most of these shifts are already past the experimental stage. The next decade is less about invention and more about how quickly these models scale to reach the people who need them.